Anastasios Grivas

647 total citations · 1 hit paper
18 papers, 450 citations indexed

About

Anastasios Grivas is a scholar working on Oncology, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Anastasios Grivas has authored 18 papers receiving a total of 450 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 5 papers in Surgery and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Anastasios Grivas's work include Multiple Myeloma Research and Treatments (3 papers), Cancer Treatment and Pharmacology (3 papers) and BRCA gene mutations in cancer (2 papers). Anastasios Grivas is often cited by papers focused on Multiple Myeloma Research and Treatments (3 papers), Cancer Treatment and Pharmacology (3 papers) and BRCA gene mutations in cancer (2 papers). Anastasios Grivas collaborates with scholars based in Greece, United States and Serbia. Anastasios Grivas's co-authors include Evangelos Lianos, Stylianos Giassas, Elias Efstathiou, Evgenia Halkia, John Spiliotis, Dimitrios T. Trafalis, Christos Tsigris, Petros N. Karamanakos, Florentia Fostira and Drakoulis Yannoukakos and has published in prestigious journals such as Annals of Oncology, Annals of Surgical Oncology and BMC Cancer.

In The Last Decade

Anastasios Grivas

17 papers receiving 434 citations

Hit Papers

Cytoreductive Surgery and HIPEC in Recurrent Epithelial O... 2014 2026 2018 2022 2014 100 200 300

Peers

Anastasios Grivas
Anastasios Grivas
Citations per year, relative to Anastasios Grivas Anastasios Grivas (= 1×) peers Enrico Maria Pasqual

Countries citing papers authored by Anastasios Grivas

Since Specialization
Citations

This map shows the geographic impact of Anastasios Grivas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anastasios Grivas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anastasios Grivas more than expected).

Fields of papers citing papers by Anastasios Grivas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anastasios Grivas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anastasios Grivas. The network helps show where Anastasios Grivas may publish in the future.

Co-authorship network of co-authors of Anastasios Grivas

This figure shows the co-authorship network connecting the top 25 collaborators of Anastasios Grivas. A scholar is included among the top collaborators of Anastasios Grivas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anastasios Grivas. Anastasios Grivas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
2.
Georgakopoulou, Vasiliki, George Kouvelos, Petros Papalexis, et al.. (2022). Characteristics and outcomes of cancer patients who develop pulmonary embolism: A cross‑sectional study. Oncology Letters. 23(5). 168–168. 5 indexed citations
3.
Psarris, Alexandros, Nektarios Koufopoulos, Anastasios Grivas, Dimitrios Papatheodorou, & Lubna Khaldi. (2020). Tumor to Tumor Metastasis from Adenocarcinoma Not Otherwise Specified of the Parotid Gland to Uterine Leiomyoma: Presentation of a Unique Case. Cureus. 12(1). e6789–e6789. 5 indexed citations
4.
Dimitriadis, Georgios K., et al.. (2019). Plerixafor-aided Mobilization of Peripheral Blood Hematopoietic Stem Cells to Support Subsequent High-dose Chemotherapy After a Prior Autologous Transplant. Clinical Lymphoma Myeloma & Leukemia. 20(2). e50–e57. 2 indexed citations
6.
Koufopoulos, Nektarios, et al.. (2019). EP336 Glassy cell carcinoma of the uterine cervix. A rare and aggressive entity. A237.2–A238. 1 indexed citations
7.
Tryfonopoulos, Dimitrios, et al.. (2018). Aromatase Inhibitor-Associated Tendinopathy and Muscle Tendon Rupture: Report of Three Cases of This Exceedingly Rare Adverse Event. Case Reports in Oncology. 11(2). 557–561. 9 indexed citations
8.
Syrios, John, Evelina Pappa, Nikolaos Volakakis, et al.. (2018). Real-World Data on Health-Related Quality of Life Assessment in Patients With Breast Cancer Receiving Subcutaneous Trastuzumab. Breast Cancer Basic and Clinical Research. 12. 2220315535–2220315535. 10 indexed citations
9.
Triantafyllidou, Olga, Ioannis S. Vlachos, Paraskevi Apostolou, et al.. (2015). Epidemiological and clinicopathological characteristics of BRCA-positive and BRCA-negative breast cancer patients in Greece.. PubMed. 20(4). 978–84. 6 indexed citations
10.
Spiliotis, John, Evgenia Halkia, Evangelos Lianos, et al.. (2014). Cytoreductive Surgery and HIPEC in Recurrent Epithelial Ovarian Cancer: A Prospective Randomized Phase III Study. Annals of Surgical Oncology. 22(5). 1570–1575. 316 indexed citations breakdown →
11.
Syrios, John, et al.. (2014). Advances in thymic carcinoma diagnosis and treatment: a review of literature. Medical Oncology. 31(7). 12 indexed citations
12.
Syrios, John, et al.. (2012). Primary signet-ring adenocarcinoma of the urinary bladder with gastric metastasis or a second primary cancer?. PubMed. 17(2). 396–396. 2 indexed citations
13.
Grivas, Anastasios, et al.. (2011). Treatment with trabectedin: should be indicated to all soft tissue sarcoma histotypes?. PubMed. 15(4). 791–3. 3 indexed citations
14.
Fostira, Florentia, Raphael Sandaltzopoulos, George Nasioulas, et al.. (2010). Screening of the DNA mismatch repair genes MLH1, MSH2 and MSH6in a Greek cohort of Lynch syndrome suspected families. BMC Cancer. 10(1). 544–544. 7 indexed citations
15.
Trafalis, Dimitrios T., et al.. (2010). CYP2E1 and risk of chemically mediated cancers. Expert Opinion on Drug Metabolism & Toxicology. 6(3). 307–319. 56 indexed citations
16.
Grivas, Anastasios, Dimitrios T. Trafalis, & A. Athanassiou. (2009). Implication of bevacizumab in fatal arterial thromboembolic incidents.. PubMed. 14(1). 115–7. 6 indexed citations
17.
Trafalis, Dimitrios T., Anastasios Grivas, & A. Athanassiou. (2009). Multiple cutaneous ecchymoses associated with the administration of bevacizumab.. PubMed. 13(4). 575–6. 1 indexed citations
18.
Konstantopoulou, Irene, Maroulio Pertesi, Florentia Fostira, Anastasios Grivas, & Drakoulis Yannoukakos. (2009). Hereditary cancer predisposition syndromes and preimplantation genetic diagnosis: where are we now?. PubMed. 14 Suppl 1. S187–92. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026